# Single and Multiple Dose Study to Explore the Safety and Pharmacokinetics of JNJ-39758979 In Healthy Male Volunteers of Either Caucasian or Japanese Descent

> **NCT01081821** · PHASE1 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 61 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** single dose NJ-39758979/ matching placebo
- **DRUG:** multi-dose JNJ-39758979 /matching placebo

## Key facts

- **NCT ID:** NCT01081821
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2013-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01081821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01081821, "Single and Multiple Dose Study to Explore the Safety and Pharmacokinetics of JNJ-39758979 In Healthy Male Volunteers of Either Caucasian or Japanese Descent". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT01081821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*